WBIO WPD Pharmaceuticals Inc.
WPD Pharmaceuticals Inc. does not have any significant operations. Previously, it was engaged in the research and development of biological compounds and small molecules. The company is headquartered in Vancouver, Canada.…
Industry Peers
BiotechnologyKey Statistics
About WPD Pharmaceuticals (CNSX: WBIO)
›
WPD Pharmaceuticals (CNSX: WBIO) is listed on the Canadian Securities Exchange, where its shares trade in CAD. It belongs to the Biotechnology industry, part of the Healthcare sector.
The shares were at 0.0700 CAD on 12 November 2026, roughly unchanged over 52 weeks. Its 52-week range is 0.0700 CAD to 0.0700 CAD, and it trades at the top of that range.
At a market capitalisation of 324.76K CAD, it trades at 2.3 times trailing earnings. The median trailing P/E of its 14 largest Biotechnology peers is 35.0, a discount of 93% for WBIO.
WPD Pharmaceuticals reports return on equity of 14.4% and an operating margin of 0.0%.
Its debt exceeds its cash by 381.54K CAD. Its Piotroski F-score is 2 out of 9, a weak reading of its financial health.